Parsons James T.

SEC Form 4 insider trading activity

Parsons James T. has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including ONCY, DMAC, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Mar 13, 2026.

On the most recent filing, Parsons James T. is listed as Director at ONCOLYTICS BIOTECH INC. Inside the rolling window, Parsons James T. reported 1 open-market purchase totaling $10K in ONCY and no open-market sales.

Companies traded

Other insiders at ONCY

Insider Buying

$10K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

2

in the rolling window

Source
ONCY
Parsons James T.
Purchase$10KMar 13SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Parsons James T. made?

Parsons James T. has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including ONCY, DMAC since 2025.

Which companies does Parsons James T. trade?

Parsons James T. has filed SEC Form 4 disclosures for 2 companies, including ONCY, DMAC.

When was Parsons James T.'s most recent SEC Form 4 filing?

Parsons James T.'s most recent SEC Form 4 filing on Tracefour is dated Mar 13, 2026.

What is Parsons James T.'s total buy and sell value in the current window?

Inside the rolling retention window, Parsons James T. bought $10K and sold $0 based on SEC Form 4 filings.

What was Parsons James T.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 10,000 ONCY shares on 2026-03-11, worth $10K, per SEC Form 4 filings.